In a significant move towards bolstering indigenous manufacturing capabilities in the pharmaceutical sector, the Technology Development Board (TDB) has forged an agreement with M/s Alchem Synthon Pvt. Ltd., based in Mumbai. Under this agreement, TDB will extend a loan assistance of ₹8.6 crores towards the project titled “Development and Commercialization of Advanced Pharmaceutical Intermediates, Fine & Specialty Chemicals,” with a total project cost of ₹19.01 crores.
This collaboration aligns closely with the Government of India’s flagship initiatives, particularly the Make in India campaign, aimed at establishing India as a global manufacturing hub. Alchem Synthon, committed to enhancing its market share as an alternative supplier of pharmaceutical intermediates and fine chemicals, particularly for companies seeking to diversify their sourcing away from China, stands at the forefront of this endeavor.
The project’s objective is to establish a cutting-edge manufacturing facility dedicated to large-scale production of Key Starting Materials (KSMs) and Advanced Intermediates essential for Active Pharmaceutical Ingredients (APIs) meeting stringent quality standards. Additionally, the facility will produce Specialty and Fine Chemicals tailored to various applications across industries such as polymer and water treatment.
Alchem Synthon specializes in research and development, focusing on designing and implementing novel, non-infringing, and commercially viable processes for manufacturing API intermediates and chemicals. The quality of these intermediates is paramount for ensuring the production of pure and effective APIs, thereby positively impacting public health outcomes.
Upon completion, the new manufacturing facility is expected to significantly increase production capacity, targeting an output of 12,000 Kg per month compared to the existing capacity of 1,000 Kg per month. Moreover, the facility will prioritize the synthesis of new intermediates and KSMs, addressing the needs of bulk drug and agrochemical industries that currently rely on imports for these critical chemicals.
By enhancing domestic production capacity and reducing dependence on imports, the project contributes substantially to the Atmanirbhar Bharat initiative, promoting self-reliance and reducing foreign exchange outflows.
Commenting on the collaboration, Shri Rajesh Kumar Pathak, Secretary, TDB, emphasized the importance of Alchem Synthon’s focus on designing innovative and commercially viable processes. He noted that this approach not only drives niche market growth but also reduces industry dependence on imported KSMs and advanced intermediates, crucial for various sectors such as the polymer industry and water treatment facilities.
Read Now:Study Finds Microplastics in Arterial Plaque, Raises Health Concerns
